Research Interests
Use of 'omics and next-generation sequencing platforms for the discovery of biomarkers for risk prognostication and therapeutic stratification, particularly neuroblastoma, sarcomas, and paediatric renal tumours
Preclinical evaluation of novel targeted agents and therapeutic strategies using structured preclinical trials
Development of orthotopic xenograft and explant models of paediatric solid tumors for comprehensive preclinical testing of novel multimodal therapeutic strategies.